Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mohammady, Anahita
NCT03952078: A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma	Active, not recruiting	1	151	US, RoW	CPI-818	Corvus Pharmaceuticals, Inc.	T-cell Lymphoma	04/26	04/26